Endomyocardial biopsy (EMB) is a critical tool for the diagnosis and management of cardiac diseases, as well as to gauge allograft rejection post heart transplant.¹ Traditional EMB techniques can be difficult, time-consuming without adequate image guidance, and may carry a risk of complications or inconclusive diagnosis attributed to crush artifact or inadequate specimen yield.²
The Jawz Endomyocardial Biopsy Forceps from Argon Medical( Athens,TX. USA)is a device designed to simplify the EMB procedure by optimizing excisional removal of myocardium. This paper will review the safety and efficacy of the Jawz biopsy forceps, including data from cited studies and bench top model comparison to the Cordis bioptome (Cordis Medical, Miami Lakes,FL.USA)